TWiV 1353: Phage bet-hedging and EBV antibodies

This Week in Virology by Vincent Racaniello

Aug 30, 202601:52:01Science & Medicine

TWiV explores how bacteriophages enable bet-hedge against bacterial immune defenses, and how transgenic mice engineered to produce human antibodies yielded potent anti-EBV candidates targeting gp350 and gp42, a promising...

Related Episodes

Continue listening to more episodes from This Week in Virology.

TWiV 1363: A Cauldron of Bats

Oct 4, 2026 - 01:53:39

TWiV explains a study testing how 16 hypothesized social and environmental drivers impact disease outbrea...

TWiV 1362: Clinical Update with Dr. Daniel Griffin

Oct 3, 2026 - 53:34

In his weekly clinical update, Daniel Griffin and Vincent Racaniello continue their ongoing exasperation...

TWiV 1361: Ancient Viral Sword and Shield

Sep 27, 2026 - 01:46:10

TWiV explains discovery of a previously unknown mechanism of RNA-guided DNA recognition for genetic contr...

TWiV 1360: Clinical Update with Dr. Daniel Griffin

Sep 26, 2026 - 01:00:27

In his weekly clinical update, Daniel Griffin and Vincent Racaniello frustration continues over the incre...

TWiV 1359: SSPE, the Long Shadow of Measles

Sep 20, 2026 - 01:10:13

Roberto Cattaneo and Kalpana Yadav join TWiV at the 2026 meeting of the American Society for Virology to...

TWiV 1358: Clinical Update with Dr. Daniel Griffin

Sep 19, 2026 - 53:59

In his weekly clinical update, Daniel Griffin and Vincent Racaniello are angered by the continuous report...

TWiV 1357: Furin, Naturally with Paul Bieinasz

Sep 13, 2026 - 01:44:17

Paul Bieniasz joins TWiV to discuss his lab's discovery that the coronavirus nuclease NSP15 cuts viral RN...

TWiV 1356: Clinical update with Dr. Daniel Griffin

Sep 12, 2026 - 47:17

In his weekly clinical update, Daniel Griffin and Vincent Racaniello delve into dengue virus infections i...